Evidence map›Paper›PMID 35798749›Full record

ArticleNPJ biofilms and microbiomes2022

A previously uncharacterized gene, PA2146, contributes to biofilm formation and drug tolerance across the ɣ-Proteobacteria.

Matthew F Kaleta, Olga E Petrova, Claudia Zampaloni, Fernando Garcia-Alcalde, Matthew Parker, Karin Sauer

Open access · goldAbstract read
In one paragraph

Article in NPJ biofilms and microbiomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Transcriptional and cellular reprogramming inCurrent research in microbial sciences · 2026
    Article
  5. Article
  6. Multidrug-resistantVirulence · 2025
    Review
  7. Article
  8. Swarm-seq Reveals Functional Divergence in CsrA Homologs Across Bacteria.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Direct prediction of antimicrobial resistance inFrontiers in microbiology · 2024
    Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Matthew F KaletaDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.
Olga E PetrovaDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.
Claudia ZampaloniRoche Pharma Research and Early Development, Immunology, Inflammation and Infectious Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Fernando Garcia-AlcaldeRoche Pharma Research and Early Development, Immunology, Inflammation and Infectious Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070, Basel, Switzerland.
Matthew ParkerDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA.
Karin SauerDepartment of Biological Sciences, Binghamton University, Binghamton, NY, 13902, USA. ksauer@binghamton.edu.ORCID 0000-0002-1177-6328
Binghamton University · USRoche (Switzerland) · CH

Funding

Role of PA4878 in biofilm antimicrobial resistanceR01AI080710 · NIAID · STATE UNIVERSITY OF NY,BINGHAMTON · PI LAU, GEE W, SAUER, KARIN · 2009 to 2020
$3.1M
NIAID NIH HHS R01 AI080710
6 · The paper itself

Abstract

Transcriptomic studies have revealed a large number of uncharacterized genes that are differentially expressed in biofilms, which may be important in regulating biofilm phenotypes such as resistance to antimicrobial agents. To identify biofilm genes of unknown function in P. aeruginosa, we made use of RNA-seq and selected 27 uncharacterized genes that were induced upon biofilm growth. Biofilms by respective mutants were subsequently analyzed for two biofilm characteristics, the biofilm architecture and drug susceptibility. The screen revealed 12 out of 27 genes to contribute to biofilm formation and 13 drug susceptibility, with 8 genes affecting both biofilm phenotypes. Amongst the genes affecting both biofilm phenotypes was PA2146, encoding a small hypothetical protein that exhibited some of the most substantial increases in transcript abundance during biofilm growth by P. aeruginosa PAO1 and clinical isolates. PA2146 is highly conserved in ɣ-proteobacteria. Inactivation of PA2146 affected both biofilm phenotypes in P. aeruginosa PAO1, with inactivation of homologs in Klebsiella pneumoniae and Escherichia coli having similar effects. Heterologous expression of PA2146 homologs complemented the P. aeruginosa ∆PA2146, suggesting that PA2146 homologs substitute for and play a similar role as PA2146 in P. aeruginosa.

Indexed as

GammaproteobacteriaGene Expression Regulation, BacterialBacterial ProteinsBiofilmsDrug TolerancePseudomonas aeruginosaBacterial Proteins

Identifiers

PMID35798749
PMCPMC9262955
OpenAlexW4284693621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.